Hyperglycaemia News and Research

RSS

A small protein could provide a revolutionary approach to tackling obesity-related diseases

Research published today shows that a peptide (small protein) called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases such as hepatic steatosis (fatty liver).

9 Mar 2023

Study explores how different clusters of cardiometabolic conditions increase dementia risk in older adults

People in the United States and England who have multiple cardiometabolic conditions such as diabetes and high systolic blood pressure are more likely to develop dementia than their peers who are relatively healthy, according to new research from the University of Surrey.

24 Jan 2023

What is the association between diabetes and SARS-CoV-2 infections?

Researchers explored whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can expedite or trigger the development of diabetes mellitus (DM).

15 Nov 2022

World Diabetes Day 2022: The Importance of Type 1 Research and Awareness with JDRF

For World Diabetes Day 2022, News-Medical speaks to JDRF, the type 1 diabetes charity, about the importance of type 1 diabetes research and awareness, as well as dispelling the misconceptions behind this autoimmune condition.

14 Nov 2022

Pancreatic cancer could be detected up to three years earlier than current diagnoses

Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests.

1 Nov 2022

Research finds a new way for the treatment of hypoglycemia

New research has taken an important step towards the goal for a treatment for the common diabetes complication hypoglycemia, or low blood sugar.

17 Dec 2021

Metformin can help counter mitochondrial dysfunction in patients with type-2 diabetes

Research staff have shown that metformin, an efficient drug against type-2 diabetes, can improve the mitochondrial function in patients with this disease.

9 Aug 2021

Artificial pancreas may soon help patients with type 2 diabetes

An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis. Tests led by the University of Cambridge and Inselspital, University Hospital of Bern, Switzerland, show that the device can help patients safely and effectively manage their blood sugar levels and reduce the risk of low blood sugar levels.

4 Aug 2021

Study: High blood sugar may worsen COVID-19 outcomes and mortality rates for non-diabetics

Abnormally high blood sugar may worsen outcomes and mortality rates for COVID-19 patients, including those without diabetes, according to major research published in the peer-reviewed open access journal Annals of Medicine.

23 Nov 2020

Coventry University professor develops new medical simulator for delivering blood glucose training

An innovative new medical simulator that teaches students and patients how to measure and analyze blood glucose has been developed by a Coventry University Professor.

12 Nov 2020

Study sheds light on molecular and cellular mechanisms that cause type 2 diabetes

Since 2004, Claude Knauf (INSERM) and Patrice Cani (UCLouvain) have been collaborating on molecular and cellular mechanisms in order to understand the causes of the development of type 2 diabetes and above all to identify new therapeutic targets.

6 Oct 2020

Urbanization in India may be associated with increase in cardiometabolic risk factors

Although the health benefits of green space are supported by a growing body of evidence, few studies on this topic have been carried out in low- and middle-income countries.

11 May 2020

A step towards precision medicine for the management of monogenic diabetes

Diabetes affects more than 400 million people worldwide and is a major public health problem. Although commonly referred to as a single disease, it actually constitutes a group of metabolic disorders with hyperglycemia as a common feature. Of all its forms, monogenic diabetes - due to a mutation in one of the genes involved in the management of blood sugar levels - affects 1% to 4% of all cases of diabetes.

22 Feb 2020

New discovery paves way for better treatment of diabetes

Insulin, a hormone essential for regulating blood sugar and lipids, is normally produced by pancreatic β cells. In many people with diabetes, however, pancreatic cells are not (or no longer) functional, causing a chronic and potentially fatal insulin deficiency that can only be controlled through daily insulin injections.

16 Oct 2019

Early combination therapy provides long-term benefits for patients with type 2 diabetes

A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.

19 Sep 2019

Innovative transplantation technique helps find early signs of type 1 diabetes

By the time type 1 diabetes is diagnosed, most of the insulin-producing beta cells have already been destroyed.

15 May 2019

Best trained alert dogs have potential to improve Type 1 diabetes patients' quality of life

New research by the University of Bristol in collaboration with Medical Detection Dogs has found that the best trained alert dogs have the potential to vastly improve the quality of life of people living with Type 1 diabetes.

16 Jan 2019

Study: Targeting specific genomic mutation in breast cancer improves survival

Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced breast cancer with the alpha-specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib significantly improves progression-free survival, according to late-breaking results reported at ESMO 2018.

22 Oct 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.

3 Oct 2018